These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33581650)
1. Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function. Song X; Gao J; Liu H; Liu X; Tang K Biomed Pharmacother; 2021 May; 137():111289. PubMed ID: 33581650 [TBL] [Abstract][Full Text] [Related]
2. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway. Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648 [TBL] [Abstract][Full Text] [Related]
3. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice. Xiang L; Liu A; Xu G Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615 [TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus. Wolf VL; Taylor EB; Ryan MJ Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322 [TBL] [Abstract][Full Text] [Related]
5. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus. Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258 [TBL] [Abstract][Full Text] [Related]
6. Aconitine: A potential novel treatment for systemic lupus erythematosus. Li X; Gu L; Yang L; Zhang D; Shen J J Pharmacol Sci; 2017 Mar; 133(3):115-121. PubMed ID: 28302448 [TBL] [Abstract][Full Text] [Related]
7. [Study on experimental systemic lupus erythematosus mouse model induced by pristane]. Li JZ; Ding J; Merim B; Li HW; Zhang Y; Shen H; Chen XJ; Wang SJ; Wang Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):119-22. PubMed ID: 21315035 [TBL] [Abstract][Full Text] [Related]
8. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus. Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427 [TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus. Pannu N; Bhatnagar A Immunobiology; 2020 Jan; 225(1):151871. PubMed ID: 31780314 [TBL] [Abstract][Full Text] [Related]
10. Progranulin mediates the onset of pristane induced systemic lupus erythematosus. He M; Hettinghouse A; Bi Y; Chen Y; Liu C Adv Rheumatol; 2024 Sep; 64(1):67. PubMed ID: 39252120 [TBL] [Abstract][Full Text] [Related]
11. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics. Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223 [TBL] [Abstract][Full Text] [Related]
12. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation. Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201 [TBL] [Abstract][Full Text] [Related]
13. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis. Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649 [TBL] [Abstract][Full Text] [Related]
14. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248 [TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007 [TBL] [Abstract][Full Text] [Related]
16. Effect of Xuebijing injection on systemic lupus erythematosus in mice. Wang YB; Wang Q; Yao YM; Sheng ZY; Liu YF Chin J Integr Med; 2013 Sep; 19(9):675-82. PubMed ID: 23975132 [TBL] [Abstract][Full Text] [Related]
17. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice. Moon JS; Mun CH; Kim JH; Cho JY; Park SD; Park TY; Shin JS; Ho CC; Park YB; Ghosh S; Bothwell ALM; Lee SW; Lee SK Kidney Int; 2018 May; 93(5):1118-1130. PubMed ID: 29409726 [TBL] [Abstract][Full Text] [Related]
18. CD4 Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848 [TBL] [Abstract][Full Text] [Related]
19. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation. Li X; Wang M; Hong H; Luo C; Liu Z; Yang R Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025 [TBL] [Abstract][Full Text] [Related]
20. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus. Calvani N; Satoh M; Croker BP; Reeves WH; Richards HB Kidney Int; 2003 Sep; 64(3):897-905. PubMed ID: 12911539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]